vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与ZIPRECRUITER, INC.（ZIP）财务数据对比。点击上方公司名可切换其他公司
ZIPRECRUITER, INC.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍（$111.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 0.6%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $7.6M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -4.4%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ZipRecruiter, Inc.是一家美国线上招聘平台企业，主打面向求职者与招聘方的求职招聘匹配服务，为双方提供高效对接的人才服务市场，帮助求职者快速找到适配岗位，也助力企业高效完成招聘需求。
PBYI vs ZIP — 直观对比
营收规模更大
ZIP
是对方的1.5倍
$75.5M
营收增速更快
PBYI
高出27.1%
0.6%
自由现金流更多
PBYI
多$6.8M
$7.6M
两年增速更快
PBYI
近两年复合增速
-4.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $111.7M |
| 净利润 | — | $-835.0K |
| 毛利率 | 69.3% | 89.1% |
| 营业利润率 | 22.7% | 3.6% |
| 净利率 | — | -0.7% |
| 营收同比 | 27.7% | 0.6% |
| 净利润同比 | — | 92.3% |
| 每股收益（稀释后） | $0.26 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIZIP
| Q4 25 | $75.5M | $111.7M | ||
| Q3 25 | $54.5M | $115.0M | ||
| Q2 25 | $52.4M | $112.2M | ||
| Q1 25 | $46.0M | $110.1M | ||
| Q4 24 | $59.1M | $111.0M | ||
| Q3 24 | $80.5M | $117.1M | ||
| Q2 24 | $47.1M | $123.7M | ||
| Q1 24 | $43.8M | $122.2M |
净利润PBYIZIP
| Q4 25 | — | $-835.0K | ||
| Q3 25 | $8.8M | $-9.8M | ||
| Q2 25 | $5.9M | $-9.5M | ||
| Q1 25 | $3.0M | $-12.8M | ||
| Q4 24 | — | $-10.8M | ||
| Q3 24 | $20.3M | $-2.6M | ||
| Q2 24 | $-4.5M | $7.0M | ||
| Q1 24 | $-4.8M | $-6.5M |
毛利率PBYIZIP
| Q4 25 | 69.3% | 89.1% | ||
| Q3 25 | 77.7% | 89.1% | ||
| Q2 25 | 76.5% | 89.3% | ||
| Q1 25 | 77.1% | 89.4% | ||
| Q4 24 | 76.4% | 89.6% | ||
| Q3 24 | 63.9% | 89.4% | ||
| Q2 24 | 77.4% | 89.5% | ||
| Q1 24 | 75.5% | 89.1% |
营业利润率PBYIZIP
| Q4 25 | 22.7% | 3.6% | ||
| Q3 25 | 17.6% | -4.4% | ||
| Q2 25 | 12.7% | -5.9% | ||
| Q1 25 | 8.7% | -10.6% | ||
| Q4 24 | 22.6% | -3.6% | ||
| Q3 24 | 27.4% | -2.8% | ||
| Q2 24 | -4.6% | 7.6% | ||
| Q1 24 | -5.3% | -0.7% |
净利率PBYIZIP
| Q4 25 | — | -0.7% | ||
| Q3 25 | 16.2% | -8.5% | ||
| Q2 25 | 11.2% | -8.5% | ||
| Q1 25 | 6.5% | -11.7% | ||
| Q4 24 | — | -9.7% | ||
| Q3 24 | 25.2% | -2.2% | ||
| Q2 24 | -9.6% | 5.7% | ||
| Q1 24 | -11.0% | -5.3% |
每股收益（稀释后）PBYIZIP
| Q4 25 | $0.26 | $-0.03 | ||
| Q3 25 | $0.17 | $-0.11 | ||
| Q2 25 | $0.12 | $-0.10 | ||
| Q1 25 | $0.06 | $-0.13 | ||
| Q4 24 | $0.40 | $-0.10 | ||
| Q3 24 | $0.41 | $-0.03 | ||
| Q2 24 | $-0.09 | $0.07 | ||
| Q1 24 | $-0.10 | $-0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $188.0M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $-77.2M |
| 总资产 | $216.3M | $569.7M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIZIP
| Q4 25 | $97.5M | $188.0M | ||
| Q3 25 | $94.4M | $211.8M | ||
| Q2 25 | $96.0M | $203.5M | ||
| Q1 25 | $93.2M | $221.1M | ||
| Q4 24 | $101.0M | $218.4M | ||
| Q3 24 | $96.7M | $225.6M | ||
| Q2 24 | $96.8M | $271.7M | ||
| Q1 24 | $107.2M | $282.5M |
总债务PBYIZIP
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIZIP
| Q4 25 | $130.3M | $-77.2M | ||
| Q3 25 | $115.3M | $-76.1M | ||
| Q2 25 | $104.7M | $-65.9M | ||
| Q1 25 | $97.1M | $-11.3M | ||
| Q4 24 | $92.1M | $13.4M | ||
| Q3 24 | $71.1M | $13.6M | ||
| Q2 24 | $48.5M | $24.4M | ||
| Q1 24 | $51.0M | $12.7M |
总资产PBYIZIP
| Q4 25 | $216.3M | $569.7M | ||
| Q3 25 | $202.9M | $573.6M | ||
| Q2 25 | $194.9M | $592.4M | ||
| Q1 25 | $196.2M | $629.4M | ||
| Q4 24 | $213.3M | $664.1M | ||
| Q3 24 | $220.7M | $652.0M | ||
| Q2 24 | $205.0M | $665.3M | ||
| Q1 24 | $214.1M | $662.4M |
负债/权益比PBYIZIP
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $7.7M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $7.6M |
| 自由现金流率自由现金流/营收 | 19.1% | 6.8% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $9.9M |
8季度趋势，按日历期对齐
经营现金流PBYIZIP
| Q4 25 | $14.4M | $7.7M | ||
| Q3 25 | $9.7M | $2.6M | ||
| Q2 25 | $14.1M | $10.5M | ||
| Q1 25 | $3.6M | $-9.9M | ||
| Q4 24 | $15.6M | $12.5M | ||
| Q3 24 | $11.0M | $9.3M | ||
| Q2 24 | $1.0M | $21.9M | ||
| Q1 24 | $11.2M | $2.0M |
自由现金流PBYIZIP
| Q4 25 | $14.4M | $7.6M | ||
| Q3 25 | $9.7M | $2.2M | ||
| Q2 25 | $14.1M | $10.2M | ||
| Q1 25 | $3.6M | $-10.2M | ||
| Q4 24 | $15.6M | $12.0M | ||
| Q3 24 | $11.0M | $9.2M | ||
| Q2 24 | $1.0M | $21.7M | ||
| Q1 24 | — | $1.9M |
自由现金流率PBYIZIP
| Q4 25 | 19.1% | 6.8% | ||
| Q3 25 | 17.7% | 1.9% | ||
| Q2 25 | 26.8% | 9.1% | ||
| Q1 25 | 7.7% | -9.3% | ||
| Q4 24 | 26.4% | 10.8% | ||
| Q3 24 | 13.7% | 7.8% | ||
| Q2 24 | 2.1% | 17.6% | ||
| Q1 24 | — | 1.6% |
资本支出强度PBYIZIP
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.1% | 0.3% | ||
| Q4 24 | 0.0% | 0.4% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.0% | 0.1% |
现金转化率PBYIZIP
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | 3.12× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
ZIP
| License | $84.3M | 75% |
| Services | $27.4M | 25% |
